After Investigation by Sanders-Led Panel, Pharma Giant Caps Inhaler Costs
By: Jake Johnson; Common Dreams “We launched an investigation into big drug companies because the prices they were charging for inhalers just didn’t add up,” said Sen. Tammy Baldwin. “And looks like we were right.” Starting in June, the German pharmaceutical giant Boehringer Ingelheim will cap co-pays for its inhalers at $35 for U.S. patients—a decision that came just two months after